Cardiac Resynchronization Therapy
GPTKB entity
Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Medicine
|
| gptkbp:can_be_combined_with |
implantable cardioverter-defibrillator
|
| gptkbp:can_lead_to |
improved exercise capacity
|
| gptkbp:can_provide |
reducing heart failure symptoms
|
| gptkbp:enhances |
quality of life
cardiac output left ventricular function |
| https://www.w3.org/2000/01/rdf-schema#label |
Cardiac Resynchronization Therapy
|
| gptkbp:improves |
heart function
|
| gptkbp:involves |
implantation of a device
the use of a pacemaker |
| gptkbp:involves_the_placement_of |
leads in the heart
|
| gptkbp:is_a_form_of |
cardiac pacing
|
| gptkbp:is_a_form_of_therapy_that |
addresses electrical conduction issues in the heart
|
| gptkbp:is_a_key_component_of |
advanced heart failure management
|
| gptkbp:is_a_non-pharmacological_approach_to |
heart failure treatment
|
| gptkbp:is_a_procedure_that_can |
improve patient outcomes
help alleviate heart failure symptoms. help manage heart rhythm disorders |
| gptkbp:is_a_procedure_that_may |
reduce the need for heart transplants
|
| gptkbp:is_a_treatment_modality_for |
chronic heart failure
|
| gptkbp:is_a_treatment_that_may |
improve exercise tolerance
|
| gptkbp:is_associated_with |
reduced hospital readmissions
reduced symptoms of heart failure biventricular pacing improved functional capacity improved left ventricular ejection fraction |
| gptkbp:is_based_on |
the principle of resynchronizing heart contractions
|
| gptkbp:is_beneficial_for |
patients with ischemic heart disease
|
| gptkbp:is_considered |
patients with QRS duration greater than 120 ms
|
| gptkbp:is_evaluated_by |
clinical trials
echocardiography |
| gptkbp:is_indicated_for |
patients with New York Heart Association class III or IV heart failure
patients with symptomatic heart failure |
| gptkbp:is_linked_to |
improved survival rates
|
| gptkbp:is_monitored_by |
gptkb:healthcare_professionals
|
| gptkbp:is_often_recommended_after |
optimal medical therapy
|
| gptkbp:is_often_used_in |
medication therapy
|
| gptkbp:is_often_used_in_patients_with |
left bundle branch block
|
| gptkbp:is_part_of |
heart failure management
|
| gptkbp:is_recommended_for |
patients with reduced ejection fraction
|
| gptkbp:is_supported_by |
gptkb:guidelines
|
| gptkbp:known_as |
CRT
|
| gptkbp:may_decrease |
mortality rates
|
| gptkbp:performed_at |
local anesthesia
|
| gptkbp:performed_by |
cardiologists
|
| gptkbp:performed_in |
in an outpatient setting
|
| gptkbp:reduces |
hospitalizations
|
| gptkbp:requires |
regular follow-up
device programming patient selection criteria |
| gptkbp:specialties |
improves cardiac synchronization
|
| gptkbp:strategy |
optimize heart function
|
| gptkbp:suitable_for |
all heart failure patients
|
| gptkbp:targets |
ventricular dyssynchrony
|
| gptkbp:treatment |
patients with atrial fibrillation
systolic heart failure can enhance quality of life |
| gptkbp:type_of |
electrophysiological therapy
|
| gptkbp:used_for |
heart failure
|
| gptkbp:bfsParent |
gptkb:Dr._N._A._Mark_Estes_III
|
| gptkbp:bfsLayer |
9
|